• HOME
• ABOUT
• TEAM
  • DaneVest Tech Fund Advisors Team
    • Terrence R. Wall - General Partner
    • Joseph P. Hildebrandt - General Partner
    • Leon R. Wilkosz - President - DaneVest Capital
    • Jason W. Joanis - Investment Manager - DaneVest Capital
  • Fund Advisory Board
    • Terrence R. Wall, Co-Chair
    • Joseph P. Hildebrandt, Co –Chair
    • Greg Dombrowski
    • Elizabeth L. R. Donley
    • Timothy J. Mathison
    • Jeffrey Rusinow
    • Tom Still
  • Investment Committee
    • Mark Bugher, Chair
    • Ken J. Ballweg
    • Curt D. Bembenek
    • Senator Robert Cowles
    • Elizabeth L. R. Donley
    • Ryan Kubly
    • Timothy J. Mathison
    • Henriette L. McLean
    • Joseph P. Hildebrandt
    • Bruce D. Neviaser
    • Stig L. Rahm
    • Richard R. Straus
    • Terrence R. Wall
  • Technology Advisory Board
    • Steve Entine
    • Lauren Flanagan
    • Robert M. Hopton
    • David Kettner
    • R. Andrew Morgan
    • C. Basil Mundy II
• APPROACH
• PORTFOLIO COMPANIES
• NEWS/EVENTS
• CONTACT
• COMPANIES SEEKING CAPITAL
• LEGAL NOTICES
  • Disclaimer
  • Privacy Notice
• DANEVEST CAPITAL

Basil Mundy is Co-Manager of Wisconsin Investment Partners and helps lead their due diligence efforts on life science companies. He is a member of the original team that formed Ortho Biotech Inc. (Johnson and Johnson). Mr. Mundy is a business development and government affairs executive with extensive senior management experience in the biotechnology and pharmaceutical industries, including over 20 years in the transplantation and dialysis marketplaces. He managed marketing and business development for The National Kidney Foundation, Schein Pharmaceutical, Inc, Bayer Pharmaceutical, MGI Pharma, Celltech (Medeva) Pharmaceuticals and Bone Care International.

P.O. BOX 7792 • MADISON, WI 53707 • 608-830-2990 • 877-DANEVST

Disclaimer >> Privacy Policy >> ©2008 DaneVest Capital LLC